Braizon Therapeutics

Developer of drug delivery technology for CNS disorders

placeTokyo, Tokyo, Japan calendar_todayFounded 2015 groups1 employees language braizon.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace slowing. Cited 5 times.

YearFilings
20231

Investor mix

3 investors on record; lead investors include Fast Track Initiative, SMBC Venture Capital, UTokyo Innovation Platform.

Investor typeCountShare
Venture capital3100%
Coming soon